BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Benítez JM, García-Sánchez V. Faecal calprotectin: Management in inflammatory bowel disease. World J Gastrointest Pathophysiol 2015; 6(4): 203-209 [PMID: 26600978 DOI: 10.4291/wjgp.v6.i4.203]
URL: https://www.wjgnet.com/2150-5330/full/v6/i4/203.htm
Number Citing Articles
1
Maxime M.W. De Sloovere, Dieter De Smet, Filip J. Baert, Johan Debrabandere, Hilde J.M. Vanpoucke. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel diseaseClinical Chemistry and Laboratory Medicine (CCLM) 2017; 55(9) doi: 10.1515/cclm-2016-0796
2
Efstathia Papada, Charalampia Amerikanou, Aristea Gioxari, Nick Kalogeropoulos, Andriana C. Kaliora. The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative ColitisDiagnostics 2020; 10(10): 798 doi: 10.3390/diagnostics10100798
3
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitisGastroenterología y Hepatología (English Edition) 2020; 43(1): 57 doi: 10.1016/j.gastre.2019.08.005
4
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,, Grażyna Rydzewska. Crohn’s disease activity evaluation based on imaging studies and biomarkersGastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00292
5
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases2019; : 209 doi: 10.1002/9781119289234.ch10
6
Ella Serrano, Jean-Philippe Bastard, Laurence Trystram, Soraya Fellahi, Hedi A. Soula, Sophie Thenet, Jean-Michel Oppert, Karine Clément, Christine Poitou, Laurent Genser. Serum Versus Fecal Calprotectin Levels in Patients with Severe Obesity Before and 6 Months After Roux-Y-Gastric Bypass: Report of the Prospective Leaky-Gut StudyObesity Surgery 2023; 33(12): 4017 doi: 10.1007/s11695-023-06911-w
7
Sebastián Eduardo Ibáñez Vodnizza, María Paz Poblete De La Fuente, Elisa Catalina Parra Cancino. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel DiseaseRheumatic Disease Clinics of North America 2020; 46(2): 275 doi: 10.1016/j.rdc.2020.01.004
8
E. Klang, U. Kopylov, R. Eliakim, N. Rozendorn, D. Yablecovitch, A. Lahat, S. Ben-Horin, M.M. Amitai. Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and video capsule endoscopyClinical Radiology 2017; 72(9): 798.e7 doi: 10.1016/j.crad.2017.04.006
9
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitisGastroenterología y Hepatología 2020; 43(1): 57 doi: 10.1016/j.gastrohep.2019.08.011
10
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel DiseasesInflammatory Bowel Diseases 2016; 22(8): 2016 doi: 10.1097/MIB.0000000000000836
11
Vanesa Jusué, María Chaparro, Javier P. Gisbert. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel diseaseDigestive and Liver Disease 2018; 50(4): 353 doi: 10.1016/j.dld.2017.12.022
12
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Reem Elbeltagi. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and consWorld Journal of Clinical Pediatrics 2024; 13(2): 93341 doi: 10.5409/wjcp.v13.i2.93341
13
Stelios Pavlidis, Calixte Monast, Matthew J. Loza, Patrick Branigan, Kiang F. Chung, Ian M. Adcock, Yike Guo, Anthony Rowe, Frédéric Baribaud, Atle van Beelen Granlund. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatmentPLOS Computational Biology 2019; 15(4): e1006951 doi: 10.1371/journal.pcbi.1006951
14
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel DiseaseGastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
15
Laurent Genser, Doriane Aguanno, Hédi A Soula, Liping Dong, Laurence Trystram, Karen Assmann, Joe‐Elie Salem, Jean‐Christophe Vaillant, Jean‐Michel Oppert, Fabienne Laugerette, Marie‐Caroline Michalski, Philippe Wind, Monique Rousset, Edith Brot‐Laroche, Armelle Leturque, Karine Clément, Sophie Thenet, Christine Poitou. Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetesThe Journal of Pathology 2018; 246(2): 217 doi: 10.1002/path.5134
16
Shahzeb Saeed, Chukwuyem Ekhator , Ali M Abdelaziz, Husnain Naveed, Amanda Karski , Daniel E Cook, Shivani M Reddy, Maryam Affaf, Salman J Khan, Sophia B Bellegarde, Abdur Rehman , Abdul Haseeb Hasan, Abdullah Shehryar. Revolutionizing Inflammatory Bowel Disease Management: A Comprehensive Narrative Review of Innovative Dietary Strategies and Future DirectionsCureus 2023;  doi: 10.7759/cureus.44304
17
Lili Wei, Mingwen Liu, Haofei Xiong. Role of Calprotectin as a Biomarker in Periodontal DiseaseMediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/3515026
18
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinalesRevue Francophone des Laboratoires 2016; 2016(484): 49 doi: 10.1016/S1773-035X(16)30223-4
19
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Milassin, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas. Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonistsExpert Opinion on Biological Therapy 2021; 21(4): 539 doi: 10.1080/14712598.2021.1890712
20
Fernando Magro, Joana Afonso, Susana Lopes, Rosa Coelho, Raquel Gonçalves, Paulo Caldeira, Paula Lago, Helena Tavares de Sousa, Jaime Ramos, Ana Rita Gonçalves, Paula Ministro, Isadora Rosa, Ana Isabel Vieira, Patrícia Andrade, João-Bruno Soares, Diana Carvalho, Paula Sousa, Tânia Meira, Joanne Lopes, Joana Moleiro, Cláudia Camila Dias, Amílcar Falcão, Karel Geboes, Fatima Carneiro. Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic EscalationEBioMedicine 2017; 21: 123 doi: 10.1016/j.ebiom.2017.06.004
21
Manoj Kumar, Selvasankar Murugesan, Nazira Ibrahim, Mamoun Elawad, Souhaila Al Khodor. Predictive biomarkers for anti-TNF alpha therapy in IBD patientsJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05058-1
22
Anuraag Jena, Vishal Sharma, Usha Dutta. Fecal calprotectin in cirrhosis—Does “ESR” of the intestine measure the liver dysfunction too?Indian Journal of Gastroenterology 2023; 42(6): 754 doi: 10.1007/s12664-023-01481-2